The role of the 'innovative therapies for children with cancer' (ITCC) European consortium.


Overall survival from childhood malignancies has dramatically improved, with survival rates now reaching over 70%. Nevertheless, some types of childhood cancer remain a difficult challenge, and for those who survive the burden of treatment can be considerable. The current paradigm for new cancer therapies is to increase our knowledge of the molecular basis… (More)
DOI: 10.1016/j.ctrv.2010.02.008


  • Presentations referencing similar topics